动脉瘤性蛛网膜下腔出血重症监护期间的目标血清钠水平
该回顾性研究连续纳入2009年1月至2015年12月确诊的动脉瘤性蛛网膜下腔出血(SAH)患者131例,旨在探讨ICU期间异常血清钠水平与不良神经功能结局(出院时改良Rankin量表3-6分)的关联并确定目标血清钠范围。多因素回归显示,年龄、Hunt-Kosnik分级、ICU期间血清钠最高值(OR 1.18,95%CI 1.05-1.35,P<0.01)和最低值(OR 0.88,95%CI 0.77-0.99,P=0.048)与不良结局显著相关。ROC曲线分析显示最高值切点为145 mmol/L、最低值切点为132 mmol/L。ICU前2周内出现低钠血症和高钠血症的患者占不良神经功能结局患者的88.2%,而血钠正常者仅占15.6%。结论认为ICU管理期间低钠血症和高钠血症均与SAH患者不良神经功能结局显著相关。
要点
- ICU期间血清钠最高值是出院不良神经功能结局的独立危险因素(OR 1.18,95%CI 1.05-1.35,P<0.01),ROC切点145 mmol/L。
- ICU期间血清钠最低值与不良结局独立相关(OR 0.88,95%CI 0.77-0.99,P=0.048),ROC切点132 mmol/L。
- ICU前2周内出现低钠血症和高钠血症者占不良结局患者的88.2%,血钠正常者仅占15.6%。
- 年龄和Hunt-Kosnik分级也是不良神经功能结局的独立预测因素。
- 该研究为回顾性单中心研究,仅提示关联,未提供干预性目标范围推荐。
适用人群与场景
- 2009年1月至2015年12月连续住院、确诊为动脉瘤性蛛网膜下腔出血(SAH)并入住ICU的患者,共131例。
诊断标准与关键阈值
- 不良神经功能结局定义为出院时改良Rankin量表(mRS)3-6分。
- ROC曲线分析显示ICU期间血清钠最高值切点为145 mmol/L,最低值切点为132 mmol/L。
研究设计与关键结果
- 研究类型为回顾性队列研究,连续纳入131例确诊SAH患者,45%出现不良神经功能结局(出院时mRS 3-6分)。
- 多因素回归分析显示,年龄、Hunt-Kosnik分级、ICU期间血清钠最高值(OR 1.18,95%CI 1.05-1.35,P<0.01)和最低值(OR 0.88,95%CI 0.77-0.99,P=0.048)与不良神经功能结局显著独立相关。
- ROC曲线分析显示血清钠最高值切点为145 mmol/L,最低值切点为132 mmol/L。
- ICU前2周内出现低钠血症和高钠血症的患者占不良神经功能结局患者的88.2%,而血钠正常者仅占15.6%。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该回顾性研究提示,SAH患者ICU期间血清钠最高值超过145 mmol/L和最低值低于132 mmol/L与出院时不良神经功能结局相关,但原文未据此给出目标血清钠的干预推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Dysnatremia commonly occur in the intensive care unit (ICU) management of patients with aneurysmal subarachnoid hemorrhage (SAH). However, detailed management strategies have not been provided even by current guidelines. The purposes of this study were to examine the association of abnormal serum sodium levels with unfavorable neurologic outcomes and to identify the target range of serum sodium in patients with SAH.
METHODS: We retrospectively reviewed all patients who were consecutively hospitalized with a confirmed diagnosis of SAH between January 2009 and December 2015. Univariate/multivariate analyses were performed to identify the independent predictors of an unfavorable neurologic outcome (modified Rankin scale of 3-6 upon hospital discharge).
RESULTS: There were 131 patients included in this study. Unfavorable neurologic outcomes occurred in 45% of patients. On multiple regression analysis, age, Hunt and Kosnik grade, and serum sodium levels in the ICU at the maximum [odds ratio (OR), 1.18; 95% CI, 1.05-1.35; P < 0.01] and minimum (OR, 0.88; 95% CI, 0.77-0.99; P = 0.048) values were significantly associated with unfavorable neurologic outcomes. The receiver operating characteristic curve analysis showed that the cut-off serum sodium levels were 145 mmol/L for maximum value and 132 mmol/L for minimum value. Patients with hyponatremia and hypernatremia during the first 2 weeks in the ICU accounted for 88.2% of patients with an unfavorable neurologic outcome; whereas, those with normal sodium levels accounted for only 15.6%.
CONCLUSIONS: In patients with SAH, both hyponatremia and hypernatremia during ICU management were significantly associated with unfavorable neurologic outcomes.
参考来源
- Okazaki T, Hifumi T, Kawakita K, et al. Target Serum Sodium Levels During Intensive Care Unit Management of Aneurysmal Subarachnoid Hemorrhage. Shock. 2017. PMID: 28498294. doi:10.1097/SHK.0000000000000897
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。